Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001140361-25-042855 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-18 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $2.98 | -6,276 | 778.3K | -0.8% | -$18.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | S | D | 6,276 | $2.98 | 778,296 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |